MILLIGAN DAVID V 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Nov 14, 2018
Insider Transaction Report
Form 4
MILLIGAN DAVID V
Director
Transactions
- Exercise/Conversion
Common Stock
2018-11-14$16.46/sh+10,000$164,600→ 30,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-11-14−10,000→ 0 totalExercise: $16.46From: 2018-06-29Exp: 2027-06-29→ Common Stock (10,000 underlying)